Cited by 297Ovarian function and disordersMenopause: Health Impacts and TreatmentsReproductive Biology and Fertility

Premature ovarian insufficiency: an international menopause society white paper

Panay, N., Anderson, R. A., Nappi, R. E., Vincent, A. J., Vujovic, S., Webber, L., Wolfman, W.·2020·Climacteric

Abstract

The aim of this International Menopause Society White Paper on premature ovarian insufficiency (POI) is to provide the latest information regarding this distressing condition. The impact of POI has far-reaching consequences due to its impact on general, psychological, and sexual quality of life, fertility prospects, and long-term bone, cardiovascular, and cognitive health. Progress in fully understanding the etiology, diagnosis, and optimal management options has been slow thus far due to the complexity of the condition and fragmented research. Recent advances in epidemiological and genetic research have improved our understanding of this condition and randomized prospective trials are being planned to determine the intervention strategies, which will optimize quality of life and long-term well-being. The International Menopause Society has commissioned a number of experts at the forefront of their specialty to define the state of the art in the understanding of this condition, to advise on practical management strategies, and to propose future research strategies. It is hoped that a global task force will subsequently be convened in order to formulate a consensus statement across key societies, to accelerate date collection and analysis of a global POI registry, and to facilitate progress in the key defined areas of research.

Integrity signals

Registry

Crossref · 10.1080/13697137.2020.1804547

Cites

174 of 174 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In postmenopausal women, micronized progesterone at these doses seems to be devoid of adverse effects on blood pressure, lipid profile, breast cancer risk, and thrombotic risk.

    “In postmenopausal women, this dose seems to be devoid of adverse effects on BP, lipid profile, breast cancer risk, and thrombotic risk.”
  • Micronized progesterone confers adequate endometrial protection when administered as part of a cyclic combined regimen (200 mg daily for 12 days each month) or as a continuous combined regimen of 100 mg per day.

    “Micronized progesterone confers adequate endometrial protection when administered as part of a cyclic combined regimen (200 mg daily for 12 days each month) or as a continuous combined regimen of 100 mg per day.”
  • Progesterone can be administered vaginally and exerts good endometrial protective effects at low serum concentrations, although there is limited evidence assessing the efficacy and optimal regimen.

    “Progesterone can be administered vaginally and exerts good endometrial protective effects at low serum concentrations, although there is limited evidence assessing the efficacy and optimal regimen.”
  • Higher estrogen doses are particularly important for achieving maximal uterine growth and development as options for fertility treatment increase.

    “This is particularly important for achieving maximal uterine growth and development as options for fertility treatment increase.”
  • Many young women with Turner syndrome benefit from a higher dose of estrogen than their older peers, exceeding 2 mg E2 orally or 50 mcg transdermally.

    “Many young women with TS benefit from a higher dose of estrogen than their older peers, that is, exceeding 2 mg E2 orally or 50 mcg TD.”

Cites

1 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Panay, N., Anderson, R. A., Nappi, R. E., Vincent, A. J., Vujovic, S., Webber, L., & Wolfman, W.
Affiliations
  • Queen Charlotte's and Chelsea Hospital (GB)
  • MRC Centre for Reproductive Health (GB)
  • University of Pavia (IT)
  • Monash Health (AU)
  • Faculty of Medicine, Clinic of Endocrinology, Diabetes and Diseases of Metabolism, Clinical Center of Serbia, University of Belgrade, Belgrade, Serbia
  • Imperial College Healthcare NHS Trust (GB)
  • Mount Sinai Hospital (CA)
Corresponding author
Panay, N.
Venue
Climacteric
Published
2020-09-02
Volume
23
Issue
5
Pages
426-446
ISSN
  • 1369-7137 (ISSN-L)
  • 1473-0804
OpenAlex
W3083923772
Cited by
297
References
174
Citations by year
2026: 43 · 2025: 59 · 2024: 53 · 2023: 48 · 2022: 61 · 2021: 30 · 2020: 3
FWCI
31.31
Type
journal article
Language
en
Open access
closed
Locations
  • Climacteric (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Biology and Fertility
Keywords
premature ovarian insufficiency, quality of life, fertility, bone health, cardiovascular health, cognitive health, etiology, diagnosis, management strategies, genetic research, consensus statement
MeSH terms
Female, Gynecology, Humans, Menopause, Societies, Medical, Primary Ovarian Insufficiency

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review